AAQ,
I assume the reason for being cautious about the new drug is because the side effects are unknown. Some believe there is potential concern that it may play with peoples DNA, the same way it does with the virus. Others argue that the few doses people will be taking is not concerning.
Which is why initially it may only be approved for high risks patients, where the benefits outweigh the potential concerns.